Search Results for "Contraceptives"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Contraceptives. Results 111 to 120 of 122 total matches.
Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) for Cystic Fibrosis
The Medical Letter on Drugs and Therapeutics • Jan 13, 2020 (Issue 1589)
patients, particularly in those who were also
taking hormonal contraceptives. Lens opacities ...
The FDA has approved Trikafta (Vertex), a fixed-dose
combination of the cystic fibrosis transmembrane
conductance regulator (CFTR) modulators elexacaftor,
tezacaftor, and ivacaftor, for oral treatment of cystic
fibrosis (CF) in patients ≥12 years old who have at
least one Phe508del mutation in the CFTR gene. About
90% of patients with CF have at least one copy of the
Phe508del (also called F508del) mutation. This is the
first approval for elexacaftor. Ivacaftor is available
alone (Kalydeco) and in 2-drug combinations with
tezacaftor (Symdeco) and lumacaftor...
Ozanimod (Zeposia) for Multiple Sclerosis
The Medical Letter on Drugs and Therapeutics • Aug 24, 2020 (Issue 1605)
effective contraception while
taking ozanimod and for 3 months after stopping it.
Ozanimod ...
The FDA has approved ozanimod (Zeposia – Celgene),
a sphingosine 1-phosphate (S1P) receptor modulator,
for treatment of adults with relapsing forms of multiple
sclerosis (MS), including clinically isolated syndrome
(initial neurological episode), relapsing-remitting
disease, and active secondary progressive MS
(SPMS). It is the third oral S1P receptor modulator to
be approved in the US for treatment of relapsing forms
of MS; siponimod (Mayzent) is also indicated for use
in adults, and fingolimod (Gilenya) is approved for use
in patients ≥10 years old.
Comparison Table: Some Drugs for HFrEF (online only)
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021 (Issue 1619)
in animal studies; women of childbearing age should use effective contraception while taking ivabradine ...
View the Comparison Table: Some Drugs for HFrEF
Drugs for Gout
The Medical Letter on Drugs and Therapeutics • Oct 30, 2023 (Issue 1688)
effect. NSAIDs
increase the risk of venous thromboembolism in
women taking oral contraceptives.2 ...
Drugs for gout are used to reduce the pain and
inflammation of acute flares, decrease the frequency
of exacerbations, and lower serum urate levels to
prevent recurrent flares, development of tophi, and
joint damage.
Med Lett Drugs Ther. 2023 Oct 30;65(1688):169-75 doi:10.58347/tml.2023.1688a | Show Introduction Hide Introduction
Comparison Table: Some Drugs for Gout (online only)
The Medical Letter on Drugs and Therapeutics • Oct 30, 2023 (Issue 1688)
contraceptives
Celecoxib is a moderate CYP2D6
inhibitor; it can increase serum concentrations
of CYP2D6 ...
View the Comparison Table: Some Drugs for Gout
Med Lett Drugs Ther. 2023 Oct 30;65(1688):e176-9 doi:10.58347/tml.2023.1688c | Show Introduction Hide Introduction
Drugs for Psoriasis
The Medical Letter on Drugs and Therapeutics • Jun 17, 2019 (Issue 1574)
the drug. Acitretin decreases the
efficacy of oral progestin-only contraceptives (minipills ...
Mild to moderate psoriasis can be treated with topical
drugs or with phototherapy. Patients with moderate to
severe disease generally require systemic therapy.
Drugs for Irritable Bowel Syndrome
The Medical Letter on Drugs and Therapeutics • Mar 23, 2020 (Issue 1594)
: Drospirenone (Slynd) — A New Progestin-Only
Oral Contraceptive
In our article on Slynd (Med Lett Drugs Ther ...
Irritable bowel syndrome (IBS) is a common disorder
characterized by recurrent abdominal pain and altered
bowel habits, often accompanied by bloating.IBS
is classified according to the predominant bowel
symptom as IBS with constipation (IBS-C), IBS with
diarrhea (IBS-D), mixed type (IBS-M), or unclassified
(IBS-U). Alterations in the microbiome, stress
responses, sensory and motor function of the gut,
and host genetic factors may be contributing factors.
Since the exact cause of IBS is unknown, the goal of
treatment is symptom control.
Drugs for Chronic Heart Failure
The Medical Letter on Drugs and Therapeutics • Jun 14, 2021 (Issue 1626)
studies with ivabradine; women of
childbearing age should use effective contraception
while taking ...
Among patients with chronic heart failure, those with
a left ventricular ejection fraction (LVEF) ≤40% are
considered to have heart failure with reduced ejection
fraction (HFrEF). Patients with a LVEF ≥50% are
considered to have heart failure with preserved ejection
fraction (HFpEF). Those with a LVEF of 41-49% are an
intermediate group more similar to patients with HFpEF.
Expanded Table: Some Drugs for Psoriasis (online only)
The Medical Letter on Drugs and Therapeutics • Jun 17, 2019 (Issue 1574)
decrease the efficacy of oral
progestin-only contraceptives
(mini-pills)
▶ Concurrent use ...
View the Expanded Table: Some Drugs for Psoriasis
Three Drugs for Atopic Dermatitis (Adbry, Cibinqo, and Rinvoq)
The Medical Letter on Drugs and Therapeutics • Apr 03, 2023 (Issue 1673)
contraception while
taking upadacitinib and for 4 weeks after stopping
the drug. Upadacitinib ...
The subcutaneously injected interleukin-13 (IL-13)
antagonist tralokinumab-ldrm (Adbry – Leo) and
the oral Janus kinase (JAK) inhibitors abrocitinib
(Cibinqo – Pfizer) and upadacitinib (Rinvoq – Abbvie)
have been approved by the FDA for treatment of
moderate to severe atopic dermatitis.
Med Lett Drugs Ther. 2023 Apr 3;65(1673):51-5 doi:10.58347/tml.2023.1673b | Show Introduction Hide Introduction